Literature DB >> 14511364

Clonidine improves postprandial baroreflex control in familial dysautonomia.

H Marthol1, M Tutaj, M Brys, C M Brown, M J Hecht, D Berlin, F B Axelrod, M J Hilz.   

Abstract

BACKGROUND: Patients with familial dysautonomia (FD) frequently experience hypertensive crises after gastrostomy feeding. The central alpha2-agonist clonidine attenuates feeding-induced crises. The aim of this study was to assess the effect of clonidine on cardiovascular autonomic modulation and particularly baroreflex sensitivity in familial dysautonomia after gastrostomy feeding.
MATERIAL AND METHODS: In nine patients, we monitored the RR-interval and systolic blood pressure at supine rest before (baseline 1) and after gastrostomy feeding (GF1). One day later, recordings were repeated after clonidine intake (baseline 2, GF2). We determined spectral powers of RR-interval and systolic blood pressure in the low- (LF) and high-frequency range (HF). Sympathovagal balance was determined from the LF/HF ratio of RR-interval. Baroreflex sensitivity was assessed from the alpha-index of systolic blood pressure and RR-interval.
RESULTS: Gastrostomy feeding decreased RR-interval, while systolic blood pressure remained stable. Clonidine induced higher RR-intervals before and after gastrostomy feeding but decreased systolic blood pressure at baseline only. Gastrostomy feeding decreased HF-power of RR-interval significantly without clonidine, but only slightly after premedication. Clonidine increased the HF-power of RR-interval slightly at baseline and significantly after gastrostomy feeding. Gastrostomy feeding increased the LF/HF ratio without clonidine only. Clonidine decreased the LF/HF ratio at baseline and after gastrostomy feeding. Gastrostomy feeding did not change baroreflex sensitivity, but baroreflex sensitivity was higher at visit 2 than visit 1.
CONCLUSIONS: In familial dysautonomia, clonidine augments baroreflex sensitivity and parasympathetic modulation. The resulting cardiovascular stabilization might attenuate feeding-induced crises.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14511364     DOI: 10.1046/j.1365-2362.2003.01242.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  2 in total

Review 1.  Current treatments in familial dysautonomia.

Authors:  Jose-Alberto Palma; Lucy Norcliffe-Kaufmann; Cristina Fuente-Mora; Leila Percival; Carlos Mendoza-Santiesteban; Horacio Kaufmann
Journal:  Expert Opin Pharmacother       Date:  2014-10-17       Impact factor: 3.889

2.  Dexmedetomidine for refractory adrenergic crisis in familial dysautonomia.

Authors:  Ryan C Dillon; Jose-Alberto Palma; Christy L Spalink; Diana Altshuler; Lucy Norcliffe-Kaufmann; David Fridman; John Papadopoulos; Horacio Kaufmann
Journal:  Clin Auton Res       Date:  2016-10-17       Impact factor: 4.435

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.